BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lucchinetti E, Lou PH, Gandhi M, Clanachan AS, Zaugg M. Differential Effects of Anesthetics and Opioid Receptor Activation on Cardioprotection Elicited by Reactive Oxygen Species-Mediated Postconditioning in Sprague-Dawley Rat Hearts. Anesth Analg 2018;126:1739-46. [PMID: 29256935 DOI: 10.1213/ANE.0000000000002676] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang S, Du X, Zhang K, Wang H. Effects of Sevoflurane on Apoptosis of Myocardial Cells in IRI Rats. Biomed Res Int 2021;2021:3347949. [PMID: 35005016 DOI: 10.1155/2021/3347949] [Reference Citation Analysis]
2 Xiao Y, Phelp P, Wang Q, Bakker D, Nederlof R, Hollmann MW, Zuurbier CJ. Cardioprotecive Properties of Known Agents in Rat Ischemia-Reperfusion Model Under Clinically Relevant Conditions: Only the NAD Precursor Nicotinamide Riboside Reduces Infarct Size in Presence of Fentanyl, Midazolam and Cangrelor, but Not Propofol. Front Cardiovasc Med 2021;8:712478. [PMID: 34527711 DOI: 10.3389/fcvm.2021.712478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Roth S, Torregroza C, Feige K, Preckel B, Hollmann MW, Weber NC, Huhn R. Pharmacological Conditioning of the Heart: An Update on Experimental Developments and Clinical Implications. Int J Mol Sci 2021;22:2519. [PMID: 33802308 DOI: 10.3390/ijms22052519] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
4 Torregroza C, Roth S, Feige K, Lurati Buse G, Hollmann MW, Huhn R. [Perioperative cardioprotection - From bench to bedside : Current experimental evidence and possible reasons for the limited translation into the clinical setting]. Anaesthesist 2021;70:401-12. [PMID: 33464375 DOI: 10.1007/s00101-020-00912-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Hou T, Ma H, Wang H, Chen C, Ye J, Ahmed AM, Zheng H. Sevoflurane preconditioning attenuates hypoxia/reoxygenation injury of H9c2 cardiomyocytes by activation of the HIF-1/PDK-1 pathway. PeerJ 2020;8:e10603. [PMID: 33391885 DOI: 10.7717/peerj.10603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Jiang Q, Gu S. Sevoflurane Postconditioning Reduces Hypoxia-Reoxygenation Injury in H9C2 Embryonic Rat Cardiomyocytes and Targets the STRADA Gene by Upregulating microRNA-107. Med Sci Monit 2020;26:e920849. [PMID: 32332694 DOI: 10.12659/MSM.920849] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Qian B, Yang Y, Yao Y, Liao Y, Lin Y. Upregulation of vascular endothelial growth factor receptor-1 contributes to sevoflurane preconditioning-mediated cardioprotection. Drug Des Devel Ther 2018;12:769-76. [PMID: 29670333 DOI: 10.2147/DDDT.S162577] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]